/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV). Such investors are...
/PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inotiv, Inc. ("Inotiv"...
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 265.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...
4D Molecular Therapeutics, Inc. (FDMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further...